Treating intrahepatic cholangiocarcinoma with pemigatinib: two case reports of Nordic patients
Background: Cholangiocarcinoma (CCA) is a diverse group of aggressive liver tumors with up to 20% being intrahepatic CCA (iCCA). Up to 15% of patients with iCCA have fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements. Here we evaluated iCCA treatment with pemigatinib, a selective...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Medical Journals Sweden
2025-04-01
|
| Rangatū: | Acta Oncologica |
| Ngā marau: | |
| Urunga tuihono: | https://medicaljournalssweden.se/actaoncologica/article/view/42073 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|